Dante Labs Announces First European Clinic With Integrated 30X Whole Genome Sequencing in Standard Clinical Care

LONDON, March 4, 2019 (Newswire.com) - Dante Labs has announced the first of hundreds of European clinics which will integrate whole genome and whole exome sequencing in standard clinical care, further making personalized medicine a standard within the European health care system.

The clinic, "Villa Letizia," is located in L’Aquila, Italy, and is the selected destination for patients across the entire Mediterranean region. Patients will receive 100X whole exome or 30X whole genome sequencing with premium turnaround time and personalized reports as part of their standard clinical care.

Villa Letizia offers specialist medical treatments in oncology, radiology, neurodegenerative diseases, rare diseases and also general surgery. With this new initiative, patients will now have access to a pharmacogenomic analyses on their adverse reaction to medications, as well as a detailed analysis of their genetic predispositions. Dante Labs’ reports will empower doctors and specialists in clinics with tools to assist in the diagnosis and treatment of patients.

“Personalized medicine should belong to everyone,” said Dante Labs CEO Andrea Riposati. “Having access to affordable whole genome sequencing should be [a right and] the standard for every patient and citizen. Our goal is to make this happen by enabling everyone to have access to the most advanced genetic technologies, especially the people in health and financial need.”

Throughout the course of 2019, Dante Labs will continue to build a network of clinics across Europe, devolving access to personalized medicine to people across the continent. Not only will we be providing personalised genetic technologies and data to our patients, we are advancing this care a step further to offer face-to-face, patient-specialist care to anticipate the age of personalised medicine for all.

Source: Dante Labs